Based on a novel multimodal nanomaterial contrast agent, a unique imaging capability with potential of delivering bioactive materials.
Based on a novel multimodal nanomaterial contrast agent with unique capability for in vivo and in biomedical imaging. It has also the potential to be used as a drug delivery of bioactive materials. Also to be used as an effective molecular marker of the engraftment of stem cells i.e. bone marrow transplant, tissue repair and replacement. The targeted market is pharmaceutical and scanner companies.